Bagsværd, Denmark, 19 March 2026 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Wegovy ® HD (once-weekly injectable semaglutide 7.2 mg) to reduce excess ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results